Topic
Medicare
41 stories related to this topic, newest first.
The Hillscience1 day ago
Medicare to Offer $50 Monthly GLP-1 Access for Weight Management Starting July
A temporary demonstration program will let some Medicare Part D enrollees obtain GLP-1 medications for a flat $50 monthly copay from July 1, 2026, through December 31, 2027. The program operates outside standard Medicare coverage rules because federal law bars payment for weight-…
washingtonmonthly.comscience3 days ago
CMS Recalculates 2026 Medicare Advantage Star Ratings After Court Found Prior Errors
Federal officials adjusted quality ratings for next year’s Medicare Advantage plans following legal pressure from insurers. The change affects bonus payments that reached $16 billion this year.
english.elpais.comscience5 days ago
U.S. Spent $360,000 Storing Contraceptives Meant for Aid
Storage costs rose from $17,000 to $24,000 monthly while usable supplies fell to $1.7 million out of $9.7 million. Medicare will cover GLP-1 weight-loss drugs for adults 65 and older starting July 2026.
prnewswire.comworld5 days ago
Lifestyle Changes Yielded Slightly Lower Multimorbidity Rates Than Metformin After 21 Years
A JAMA study of 1,173 Medicare participants found that diet and exercise reduced multimorbidity rates to 82 percent versus 85 percent for metformin and 87 percent for placebo after 21 years of follow-up.
New York Postworld6 days ago
Medicare to Offer GLP-1 Weight-Loss Drugs for $50 Monthly Starting July 1
Up to 14 million Medicare recipients who are overweight will be eligible for three GLP-1 medications at a $50 copay under a new pilot program. The Medicare GLP-1 Bridge runs from July 2026 through December 2027 and is separate from standard Part D coverage.
nbcnews.comscience7 days ago
Medicare to Cover Weight Loss Drugs for Adults 65 and Older Starting Next Month
The Trump administration will extend a transitional program called Bridge to provide coverage through the end of next year after private insurers declined to join a planned three-year demonstration.
washingtonpost.compolitics7 days ago
Florida Clinic Owner Sentenced to Nearly 10 Years for $58 Million 340B Fraud
Jean Jethro Alexandre was convicted in a Florida healthcare fraud conspiracy that submitted more than $58 million in false claims to Medicare, Medicaid, and private insurers through the federal 340B Drug Pricing Program.
medpagetoday.comscience9 days ago
Trump Administration Proposes Rule on Medicare Drug Price Negotiation Timing for Modified Drugs
The proposal targets drugmakers that add active ingredients to avoid Medicare price negotiation. It forms part of the annual rule selecting the next 20 drugs for negotiation.
nbcnews.comscience9 days ago
Trump Administration Proposes Rule on Medicare Drug Price Negotiation Timing After Ingredient Changes
@statnews reported that the Trump administration on June 12, 2026, proposed a policy change to stop drugmakers from avoiding Medicare price negotiation by adding active ingredients to existing drugs. The measure is part of the annual rule that sets the process for selecting the n…
ABC Newspolitics12 days ago
Social Security Retirement Trust Fund Projected to Deplete in 2032
An annual trustees report released Tuesday moved the projected depletion date for Social Security's main retirement fund forward by one year to 2032. Medicare's hospital insurance trust fund remains on track to exhaust reserves in 2033.
Los Angeles Timesbusiness12 days ago
Social Security Retirement Trust Fund Solvent Until 2032, Trustees Report
An annual trustees report released Tuesday moved the projected depletion date for Social Security's retirement trust fund forward one year to 2032. Medicare's hospital insurance trust fund remains on track to exhaust reserves in 2033.
Forbesfinance15 days ago
Medicare Advantage Reaches Majority (55%) of Eligible Beneficiaries in 2026 as Growth Slows and Market Remains Concentrated
KFF data show continued but slower growth in Medicare Advantage despite pullbacks by major insurers. UnitedHealth Group and Humana together hold 46% of enrollees.
foxnews.comscience16 days ago
CMS Pauses New Medicare Hospice and Home Health Enrollments
The Centers for Medicare and Medicaid Services paused new Medicare enrollments for hospice and home health agencies as part of an anti-fraud effort. Faris Flournoy, CEO of Flournoy Health Systems, said the restrictions could limit patient access while agreeing that bad actors exi…
disabilityscoop.compolitics18 days ago
Bessent Testifies on Social Security Shortfalls, Rejects Tax Hikes or Benefit Cuts, Offers 3-3-3 Growth Framework
Bessent told Congress the administration will not raise taxes or cut benefits for seniors. He presented a 3-3-3 plan to stabilize debt at 100 percent of GDP.
techjuice.pkworld20 days ago
Federal Warehouse in Southern California Stores Luxury Cars and Memorabilia Seized in Fraud Investigations
Federal authorities displayed dozens of luxury vehicles and collectibles recovered from fraud schemes. The items illustrate efforts to recover funds lost to Medicare and Medicaid fraud under the current administration.
techjuice.pkworld21 days ago
Federal Warehouse Stores Luxury Cars and Memorabilia Seized in Major Fraud Cases
CBS News reported that a secret Southern California warehouse stores dozens of Ferraris, Lamborghinis, and sports memorabilia seized in federal fraud investigations. Officials said recovery of stolen funds remains difficult as the Trump administration targets Medicare and other p…
fastcompany.combusiness21 days ago
Medicare to Offer Weight-Loss Drugs for $50 Monthly Starting in July
Medicare will begin covering Wegovy and Zepbound for weight loss at $50 per month for older adults in July. The agency has not disclosed the projected cost to taxpayers.
cnbc.comscience21 days ago
Medicare to Cover Wegovy and Zepbound for Obesity Treatment at $50 Monthly Copay Starting July 1
The temporary GLP-1 Bridge program will run through December 2027. Taxpayers will cover most costs for millions of new patients.
Substrate placeholder — needs reviewpolitics25 days ago
Justice Department to Accelerate Review of Whistleblower Complaints on Benefits Fraud
The U.S. Department of Justice will shorten its review period for certain whistleblower complaints alleging fraud against federal benefits programs. Officials said the change aims to decide within 60 to 120 days whether to pursue litigation, investigate further, or dismiss cases.
Bipartisan Policy Centerpolitics27 days ago
CMS Releases Updated Strategic Priorities at May 20 Event
The Centers for Medicare and Medicaid Services presented four strategic priorities during a May 20, 2026, discussion hosted by the Bipartisan Policy Center. The agency oversees coverage for more than 160 million Americans through Medicare, Medicaid, and the federal exchanges.
nypost.comai30 days ago
Democrats Introduce Resolutions to End Medicare AI Pilot Program
Democratic lawmakers have introduced resolutions in the House and Senate to repeal the WISeR model, a Medicare pilot using AI for prior authorization in six states. The program runs through 2031 and pays contractors based on cost savings from denied services.
Fox Newspolitics32 days ago
Alzheimer's Blood Tests Face Medicare Coverage Limits
Medicare covers tau protein blood tests only after symptoms appear. New legislation would expand coverage for earlier detection.
Fox Newstechnology33 days ago
Report Examines Medicare Scam Ads on Meta Platforms
A Center for Countering Digital Hate analysis reviewed more than 90,000 Meta ads and identified Medicare-related scam campaigns that generated 215 million impressions between March 2025 and March 2026. Meta stated it removed more than 159 million scam ads last year and disputes t…
upi.comscience33 days ago
Senate Democrats Propose Medicare Home Care Benefit
A group of Senate Democrats led by Sen. Ron Wyden proposed adding in-home care coverage to Medicare. The plan is the final part of a three-part health care package aimed at long-term care and workforce support.
Washington Examinerpolitics33 days ago
Senate Democrats Outline Long-Term Care Goals for Future Medicare Expansion
Senate Democrats sent a letter outlining goals to expand home-based care under Medicare. The letter was sent ahead of the 2028 election cycle. It focuses on workforce pay, nursing home quality, and home care access.
upi.comscience33 days ago
Senate Democrats Propose Medicare Coverage for In-Home Long-Term Care
A group of Senate Democrats has proposed adding an in-home care benefit to Medicare. The plan forms the final part of a three-part health care package and does not include cost estimates or funding details.
usatoday.comscience34 days ago
Supreme Court Declines to Hear Pharma Challenges to Medicare Drug Price Program
The U.S. Supreme Court declined to review lawsuits filed by six pharmaceutical companies against the Medicare drug price negotiation program. The White House separately announced an expansion of its TrumpRx discount platform through partnerships with three prescription savings se…
manilatimes.netpolitics34 days ago
Rural Health Gaps Limit Early Alzheimer's Detection
Rural communities face shortages of dementia specialists and limited access to diagnostic testing. New blood-based tests cleared by the Food and Drug Administration last year may reduce those barriers if Medicare coverage expands.
thenation.comworld35 days ago
Medicare Advantage brokers receive $10 billion in annual commissions
Medicare Advantage brokers collect about $10 billion yearly in commissions. The payments have drawn attention to the number of beneficiaries actually helped by the brokers.
MA
forbes.comscience36 days ago
Congress Ends Medicare Reimbursement Pilot for CBD Products
A Medicare pilot program reimbursing patients for hemp-derived products faces uncertainty after a hemp ban passed by Congress last November. The ban would take effect in November and restrict most products containing any THC.
insidermonkey.compolitics37 days ago
Trump Administration Authorizes Medicare Test Program for CBD
The Trump administration has authorized a test program allowing some Medicare patients to receive free cannabidiol, or CBD. The program will examine whether the cannabis compound can ease certain symptoms in older patients and reduce overall health care costs. It marks an initial…
Cnbcfinance38 days ago
CMS Administrator Oz Joins CNBC to Discuss Healthcare Prior Authorization Coalition and Medicare Fraud
Dr. Mehmet Oz appeared on CNBC's Squawk Box to address the formation of an industry-wide coalition of 29 healthcare companies aimed at simplifying prior authorization. Oz, Administrator of the Centers for Medicare & Medicaid Services, highlighted efforts to combat healthcare frau…
Fox Newspolitics39 days agoUpdated
CMS Imposes Six-Month Moratorium on New Hospice and Home Health Agency Medicare Enrollment
The Centers for Medicare and Medicaid Services halted new enrollments nationwide on May 13, 2026, to intensify fraud investigations. The pause, part of the Trump administration's anti-fraud efforts, follows suspensions of payments to hundreds of providers and the withholding of b…
theconservativetreehouse.comworld40 days ago
Trump Administration Launches 18-Month Medicare Pilot Capping Copays at $50 for Certain GLP-1 Weight-Loss Drugs
President Donald Trump and the Centers for Medicare & Medicaid Services unveiled an 18-month pilot that will allow qualifying Medicare Part D beneficiaries to obtain certain GLP-1 medications such as Wegovy for $50 a month beginning July 1, 2026. The program marks a major policy…
Statscience41 days ago
Medicare Spending on New Alzheimer’s Drugs Falls Below Projections
Medicare payments for recently approved Alzheimer’s medications are coming in well below earlier forecasts. A spokesperson for the Centers for Medicare and Medicaid Services said uptake of the drugs has been muted and the agency is not projecting significant spending in 2026 or 2…
foxnews.comscience42 days ago
Medicare Spending on Newly Approved Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections
Uptake of the recently approved intravenous Alzheimer’s medications has been far lower than anticipated, prompting Medicare to forecast no significant spending on Leqembi and Kisunla in 2026 or 2027. Two years ago the program projected billions of dollars annually on Leqembi alon…
Statscience42 days ago
Medicare Spending on Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections
Uptake of the recently approved intravenous medications has been far lower than anticipated, prompting the Centers for Medicare and Medicaid Services to project no significant spending in 2026 or 2027. The muted adoption marks a sharp reversal from projections made two years ago.
manilatimes.networld45 days ago
Medicare to Test $50 Monthly Co-Pay for GLP-1 Weight Loss Drugs in New Pilot Program
The Centers for Medicare and Medicaid Services announced a two-year demonstration program that will allow certain enrollees to access FDA-approved GLP-1 medications for weight loss at a fixed $50 monthly co-pay with no deductible. The Medicare GLP-1 Bridge program runs from July…
AB
Nprscience47 days ago
Medicare to Test 18-Month GLP-1 Pilot for Weight Loss Drugs Starting July 2026
The Centers for Medicare & Medicaid Services will begin a short-term pilot on July 1, 2026, allowing eligible beneficiaries to obtain certain GLP-1 medications for weight loss at a flat $50 copayment. The 18-month program bridges to a potential longer-term initiative in 2028 afte…
sbs.com.aufinance57 days agoUpdated
Average Out-of-Pocket Cost for First Australian Dermatology Visit: $230 (2025 Report)
A new Cleanbill report details average out-of-pocket costs for dermatology appointments in Australia at $230 for first visits and nearly $190 for follow-ups, with nationwide increases of almost $18 and $20 respectively over one year. The findings, based on 322 clinics, highlight…
FI
KO
SE
DE
+1
Fox Newspolitics60 days ago
Congressional Testimony Highlights Hospice Fraud Cases in California Involving Empty Facilities and False Enrollments
Witnesses testified before the House Ways and Means Committee on widespread hospice fraud in California, including empty facilities and improper enrollments. A psychotherapist described being falsely listed in hospice, denying her Medicare access. Federal crackdowns have suspende…